Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency × safinamide × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Renal Insufficiency 1 Lymphoma, Follicular 1

Interventions

glucarpidase 2 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 ripretinib 1 mirabegron 1 gamma-Glutamyl Hydrolase 1 Sitagliptin Phosphate 1 Rituximab 1 Methotrexate 1 Leucovorin 1 Lenalidomide 1 Eplerenone 1 Duration of Therapy 1 Cyclophosphamide 1 Cilengitide 1 Carboxypeptidases 1 Bendamustine Hydrochloride 1 Azacitidine 1 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01374113 2013-03-29

Safinamide Renal Impairment Trial

Newron Pharmaceuticals SPA

Phase 1 Completed

Lymphoma, Follicular, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡